| Filed On | Filing |
|---|---|
| 11 Apr 2023 |
8-K/A: Departure/Election of Directors or Officers; Compensation
I am pleased to offer you employment at Bioventus LLC (“Bioventus” or the “Company”) on the terms set forth in this offer letter agreement (the “Agreement”). This Agreement will be effective on April 5, 2023 or a mutually agreed upon dat... |
| 21 Nov 2022 |
8-K/A: Results of Operations and Financial Condition
DURHAM, NC – November 21, 2022 – Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today amended its previously announced financial results for the three and nine months ended... |
| 27 Sep 2022 |
8-K/A: Financial Statements and Exhibits
To the management and Board of Directors of CartiHeal (2009) Ltd. |
Loading...
